ArticleIJU case reports2022

Efficacy of combination therapy with pembrolizumab and axitinib for metastatic renal collecting duct cell carcinoma: A report on two cases.

Shinji Tamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.